JP2010502175A - Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法 - Google Patents

Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法 Download PDF

Info

Publication number
JP2010502175A
JP2010502175A JP2009526123A JP2009526123A JP2010502175A JP 2010502175 A JP2010502175 A JP 2010502175A JP 2009526123 A JP2009526123 A JP 2009526123A JP 2009526123 A JP2009526123 A JP 2009526123A JP 2010502175 A JP2010502175 A JP 2010502175A
Authority
JP
Japan
Prior art keywords
cells
model
monocytes
cell
idc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009526123A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502175A5 (cg-RX-API-DMAC7.html
Inventor
ベーシュトアレ,ニコラ
アンドレ,ヴァレリ
オルリー,イザベル
ペリエ,エリック
Original Assignee
ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス filed Critical ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス
Publication of JP2010502175A publication Critical patent/JP2010502175A/ja
Publication of JP2010502175A5 publication Critical patent/JP2010502175A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/097—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells oral mucosa cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1121—Dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C12N2502/1157—Monocytes, macrophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/243—Cells of the female genital tract, non-germinal ovarian cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2009526123A 2006-09-04 2007-09-03 Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法 Pending JP2010502175A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0653567A FR2905380B1 (fr) 2006-09-04 2006-09-04 Procede de production de cellules de langerhans et/ou de cellules de dentritiques interstitielles/dermiques a partir de monocytes cd14+
PCT/EP2007/059165 WO2008028882A1 (en) 2006-09-04 2007-09-03 A method for producing langerhans cells and/or dermal/interstitial dentritic cells from cd14+ monocytes

Publications (2)

Publication Number Publication Date
JP2010502175A true JP2010502175A (ja) 2010-01-28
JP2010502175A5 JP2010502175A5 (cg-RX-API-DMAC7.html) 2010-10-21

Family

ID=37781699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526123A Pending JP2010502175A (ja) 2006-09-04 2007-09-03 Cd14+単球からランゲルハンス細胞及び/又は真皮/間質性樹状細胞を製造する方法

Country Status (7)

Country Link
EP (1) EP2064318A1 (cg-RX-API-DMAC7.html)
JP (1) JP2010502175A (cg-RX-API-DMAC7.html)
KR (1) KR20090049620A (cg-RX-API-DMAC7.html)
BR (1) BRPI0716107A2 (cg-RX-API-DMAC7.html)
CA (1) CA2662231A1 (cg-RX-API-DMAC7.html)
FR (1) FR2905380B1 (cg-RX-API-DMAC7.html)
WO (1) WO2008028882A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020111265A1 (ja) * 2018-11-30 2020-06-04 株式会社 資生堂 色素沈着皮膚モデルおよびその製造方法、ならびに皮膚の色素沈着を治療または予防するための因子の評価方法
JPWO2021054079A1 (cg-RX-API-DMAC7.html) * 2019-09-17 2021-03-25

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010225438A1 (en) * 2009-03-17 2011-10-13 The Heart Research Institute Ltd Method of cell differentiation and uses therefor in screening, diagnosis and therapy
GB201700138D0 (en) 2017-01-05 2017-02-22 Senzagen Ab Analytical methods and arrays for use in the same
FR3132146B1 (fr) * 2022-01-27 2025-10-31 Genoskin Modèle humain ex vivo destiné à l’évaluation du potentiel vaccinal d’une composition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004526455A (ja) * 2001-04-27 2004-09-02 イスティテュート スペリオーレ ディ サニタ 単球から高度に活性なヒト樹状細胞を作製するための方法
JP2005518787A (ja) * 2001-12-10 2005-06-30 コレティカ invitroにおけるCD14陽性単球からの樹状細胞の産出

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743817B1 (fr) * 1996-01-23 1998-03-13 Oreal Equivalent de peau comprenant des cellules de langerhans
WO2005007839A1 (ja) * 2003-07-22 2005-01-27 Kirin Beer Kabushiki Kaisha ノッチリガンドDelta-1、GM-CSF、TGF-βを用いたヒト末梢血単核球であるCD14陽性細胞からのランゲルハンス細胞の調製方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004526455A (ja) * 2001-04-27 2004-09-02 イスティテュート スペリオーレ ディ サニタ 単球から高度に活性なヒト樹状細胞を作製するための方法
JP2005518787A (ja) * 2001-12-10 2005-06-30 コレティカ invitroにおけるCD14陽性単球からの樹状細胞の産出

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020111265A1 (ja) * 2018-11-30 2020-06-04 株式会社 資生堂 色素沈着皮膚モデルおよびその製造方法、ならびに皮膚の色素沈着を治療または予防するための因子の評価方法
CN113166694A (zh) * 2018-11-30 2021-07-23 株式会社资生堂 色素沉积皮肤模型及其制造方法、以及用于治疗或预防皮肤的色素沉积的因子的评价方法
JPWO2020111265A1 (ja) * 2018-11-30 2021-10-14 株式会社 資生堂 色素沈着皮膚モデルおよびその製造方法、ならびに皮膚の色素沈着を治療または予防するための因子の評価方法
JP7522042B2 (ja) 2018-11-30 2024-07-24 株式会社 資生堂 色素沈着皮膚モデルおよびその製造方法、ならびに皮膚の色素沈着を治療または予防するための因子の評価方法
JPWO2021054079A1 (cg-RX-API-DMAC7.html) * 2019-09-17 2021-03-25
WO2021054079A1 (ja) * 2019-09-17 2021-03-25 凸版印刷株式会社 細胞構造体及びその製造方法
CN114258428A (zh) * 2019-09-17 2022-03-29 凸版印刷株式会社 细胞结构体及其制造方法
JP7650468B2 (ja) 2019-09-17 2025-03-25 Toppanホールディングス株式会社 細胞構造体及びその製造方法

Also Published As

Publication number Publication date
EP2064318A1 (en) 2009-06-03
CA2662231A1 (en) 2008-03-13
FR2905380A1 (fr) 2008-03-07
WO2008028882A1 (en) 2008-03-13
FR2905380B1 (fr) 2008-12-05
BRPI0716107A2 (pt) 2013-09-24
KR20090049620A (ko) 2009-05-18

Similar Documents

Publication Publication Date Title
JP5101559B2 (ja) invitroにおけるCD14陽性単球からの樹状細胞の産出
Bechetoille et al. Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells
EP0032145B1 (fr) Procede pour stimuler la croissance des cellules d'epiderme humain, applications dudit procede et produits obtenus de cette maniere
JP3021379B2 (ja) ランゲルハンス細胞を含有する皮膚等価物
CN107267441B (zh) 一种建立用于抗炎抗敏功效评价的三维皮肤模型的方法
EP2280064A2 (en) Composition comprising vegetable peptone for promoting stem cell proliferation
WO2007090575A1 (de) Hautmodell mit dendritischen zellen
KR20090049620A (ko) Cd14+ 단구로부터 랑게르한스 세포 및/또는 진피/간질성 수지상 세포를 생성시키는 방법
JP2015509382A (ja) 組織構築体およびその使用
JP5892576B2 (ja) 上皮再構築体の作成方法及び該上皮再構築体を用いたスクリーニング方法
Penha et al. A comprehensive literature review: the potential of exosomes in hair growth and transplantation
JP2010502175A5 (cg-RX-API-DMAC7.html)
US20100297765A1 (en) Method for producing langerhans cells or interstitial dendritic cells or both from cd14+ monocytes
Hardy et al. Either chick embryo dermis or retinoid‐treated mouse dermis can initiate glandular morphogenesis from mammalian epidermal tissue
Khalil et al. Alkaline phosphatase-positive Langerhans cells in the epidermis of cattle
CA2410946A1 (en) In vitro tissue test system
Ayala-García et al. Participation of epidermal langerhans cells in human pathology and their potential as targets for drug development: a review of literature
DE102004061289B4 (de) Testkit mit Testzellen und Immunzellen sowie Herstellverfahren hierfür
DE102007006736B4 (de) In-vitro Testkit zur tierversuchsfreien Bestimmung des sensibilisierenden Potentials einer Substanz
WO2007031273A2 (en) Artificial immune-reconstituted epidermis equivalents
Löwa New biomedical approaches for studying (patho) physiological conditions of healthy and inflamed skin in vitro
EP1786895B1 (en) Tridimensional support for cell culture, culture method making use of such a support and stem-like cells obtained through such a method
Marti et al. Vascular endothelial growth factor inhibits dendritic cell maturation
Heckelen Donor-dependent effects of para-Phenylenediamine on human monocyte-derived dendritic cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100902

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100902

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130205

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130213

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130304

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130507

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140204